Storage is not optional
There was a 2015 Phase I human trial registered to study safety and pharmacokinetics, but published results are conspicuously missing
DOI:10.1186/s13018-019-1242-6 3.T.Huang,K.Zhang,L.Sun,X.Xue,C.Zhang,Z.Shu,N.Mu,J.Gu,W.Zhang,Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
Risks include: Age: Older folks might not absorb B12 as well
Thereby, the application of NO-agents, NOS-blockade L-NAME, NO-over-activity (L-arginine, NOS-substrate) and their relationships (opposite or parallel activities, mutual counteraction or not), which can cover all essential points of NO-system, and the full spectrum of NO-system functions was combined with BPC 157 application to show its full efficacy on maintaining and/or reestablishing NO-system effects and functions [124,125]
Extreme restriction is unnecessary and often counterproductive, causing metabolic slowdown that persists beyond the protocol